FDA guidance explores trial design, supporting data for GVHD treatments
Regulatory NewsMichele G. Sullivan
Advanced therapies/cell and gene therapyBiologics/ biosimilars/ vaccinesMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States